88494179 - ALDEYRA

Information

• Trademark
• 88494179

• Source

• Serial Number

  88494179

• Registration Number

  6154544

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  June 28, 2019
  5 years ago

• Registration Date

  September 15, 2020
  3 years ago

• Transaction Date

  September 15, 2020
  3 years ago

• Status Date

  September 15, 2020
  3 years ago

• Published for Opposition Date

  February 25, 2020
  4 years ago

• Location Date

  August 13, 2020
  3 years ago

• First Use Anywhere Date

  May 30, 2019
  5 years ago

• First Use In Commerce Date

  May 30, 2019
  5 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  BELL, MARLENE D

• Attorney Docket Number

  A2119-2003

  Attorney Name

  Ann Lamport Hammitte

  Law Office Assigned Location Code

  M90

• Owners

  • ALDEYRA THERAPEUTICS, INC. (F/K/A ALDEXA THERAPEUTICS, INC. F/K/A NEURON SYSTEMS, INC

Case File Statements

• CC0000: Color is not claimed as a feature of the mark.
• DM0000: The mark consists of the stylized letters and wording "AA ALDEYRA". The letters "AA" appear askew and the second letter "A" is inverted. Centered below the letters "AA" is the word "ALDEYRA".
• GS0051: Pharmaceutical agents for Reactive Aldehyde Species (RASP) inhibition, Dihydrofolate Reductase Inhibition, and by Heat Shock Protein 90 and chaperome Inhibition for the treatment of immune-mediated diseases, dry eye disease, allergic conjunctivitis, noninfectious anterior uveitis, Sjögren-Larsson Syndrome, immune-mediated ocular diseases, systemic diseases, proliferative vitreoretinopathy, retinal diseases, post-transplant lymphoproliferative disease, autoimmune disease, metabolic disease, and cancer; pharmaceuticals for use in treatment of immune-mediated diseases; pharmaceuticals for use in treating dry eye disease, allergic conjunctivitis, noninfectious anterior uveitis, and Sjögren-Larsson Syndrome; pharmaceuticals for treating immune-mediated ocular diseases and systemic diseases; pharmaceuticals for treating proliferative vitreoretinopathy, retinal diseases, post-transplant lymphoproliferative disease, autoimmune disease, metabolic disease, and cancer

Case File Event Statements

• 9/15/2020 - 3 years ago

  26 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 8/14/2020 - 3 years ago

  25 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA

• 8/13/2020 - 3 years ago

  24 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR

• 7/29/2020 - 3 years ago

  23 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC

• 7/13/2020 - 3 years ago

  22 - USE AMENDMENT FILED Type: IUAF

• 7/29/2020 - 3 years ago

  21 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 7/13/2020 - 3 years ago

  20 - TEAS STATEMENT OF USE RECEIVED Type: EISU

• 7/10/2020 - 3 years ago

  19 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 7/10/2020 - 3 years ago

  18 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 7/10/2020 - 3 years ago

  17 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 4/21/2020 - 4 years ago

  16 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 2/25/2020 - 4 years ago

  15 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 2/25/2020 - 4 years ago

  14 - PUBLISHED FOR OPPOSITION Type: PUBO

• 2/5/2020 - 4 years ago

  13 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 1/18/2020 - 4 years ago

  12 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 1/6/2020 - 4 years ago

  11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 1/6/2020 - 4 years ago

  10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 1/4/2020 - 4 years ago

  9 - ASSIGNED TO LIE Type: ALIE

• 12/11/2019 - 4 years ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 9/24/2019 - 4 years ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 9/24/2019 - 4 years ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 9/24/2019 - 4 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 9/18/2019 - 4 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 7/11/2019 - 4 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 7/10/2019 - 4 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 7/2/2019 - 4 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP